OverEZ is a high-quality chicken coop manufacturing company. This was started by Chet Beiler in 2020. As of September 2023, OverEZ’s net worth is $21 million. Furthermore, they’re pulling in a whopping $9 million in annual revenue.
In 2022 they appeared on Season 13 of Shark Tank USA seeking $1 million for 25% of equity valuing the company at $25 million. Kevin O’Leary offered a deal of $1 million for 4% equity and 11.5% interest paid off over three years. However, the Chet didn’t accept the offer.
OverEZ saw great success in business after their appearance in Shark Tank. As of October 2023, OverEZ is actively running operations. You can purchase OverEZ chicken coops through their website.
OverEZ Net Worth
Net worth | $21 million (2023) |
Annual Sales Revenue | $9 million (2023) |
Profits | $1.35 million |
Lifetime sales | $21 million (2023) |
Investor | – |
Founder | Chet Beiler |
Employees | – |
OverEZ Net Worth Timeline
Net Worth 2023 | $21 million |
Net Worth 2022 | $21 million |
Net Worth 2021 | – |
Net Worth 2020 | – |
Net worth valuation in 2022 before appearing on Shark Tank | $25 million |
OverEZ Pitch on Shark Tank
Company name | OverEZ |
Product | High-quality chicken coop manufacturing company |
Episode | Season 13 Episode 13 |
Founder | Chet Beiler |
Asked for | $1 million for 25% Equity |
Final deal | No deal |
Shark / Sharks | None |
Location | Houston, Texas |
Don’t miss these product from Season 13
OverEZ Founder
OverEZ was founded by Chet Beiler in 2020. Chet has an academic background in Political Science, Economics, Business, and International Studies. Besides OverEZ he also owns other businesses. OverEZ’s founder Chet Beiler has a net worth of 21 Million USD as of 2023.
Key accomplishments
Year | Accomplishment |
2022 | The company got featured on Shark Tank |
Conclusion
From their beginnings on Shark Tank to their current status as a thriving business, they have proven that with the right idea and execution, anything is possible. We can’t wait to see the future for OverEZ and its continued success.